| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.73 | 0.007 |